Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice.
Adult
Aged
Buprenorphine
/ therapeutic use
Female
Health Knowledge, Attitudes, Practice
Humans
Inservice Training
/ organization & administration
Internal Medicine
/ education
Internship and Residency
/ organization & administration
Male
Middle Aged
Narcotic Antagonists
/ therapeutic use
Opiate Substitution Treatment
/ methods
Opioid-Related Disorders
/ drug therapy
Retrospective Studies
Buprenorphine
Education, medical, graduate
Office based opioid treatment
Opioid-related disorder
Primary care
Journal
Addiction science & clinical practice
ISSN: 1940-0640
Titre abrégé: Addict Sci Clin Pract
Pays: England
ID NLM: 101316917
Informations de publication
Date de publication:
19 12 2019
19 12 2019
Historique:
received:
29
04
2019
accepted:
11
12
2019
entrez:
21
12
2019
pubmed:
21
12
2019
medline:
4
9
2020
Statut:
epublish
Résumé
The integration of opioid use disorder (OUD) care and competencies in graduate medical education training is needed. Previous research shows improvements in knowledge, attitudes, and practices after exposure to OUD care. Few studies report outcomes for patients with OUD in resident physician continuity practices. A novel internal office-based opioid treatment (OBOT) program was initiated in a resident continuity clinic. Surveys of resident and staff knowledge and attitudes of OBOT were administered at baseline and 4 months. A retrospective chart review of the 15-month OBOT clinic obtained patient characteristics and outcomes. Twelve patients with OUD were seen in the OBOT clinic. Seven patients (58%) were retained in care at the end of the study period for a range of 9-15 months. Eight patients demonstrated a good clinical response. Surveys of residents and staff at 4 months were unchanged from baseline showing persistent lack of comfort in caring for patients with OUD. OBOT can be successfully integrated into resident continuity practices with positive patient outcomes. Improvement in resident and staff attitudes toward OBOT were not observed and likely require direct and frequent exposure to OUD care to increase acceptance.
Sections du résumé
BACKGROUND
The integration of opioid use disorder (OUD) care and competencies in graduate medical education training is needed. Previous research shows improvements in knowledge, attitudes, and practices after exposure to OUD care. Few studies report outcomes for patients with OUD in resident physician continuity practices.
METHODS
A novel internal office-based opioid treatment (OBOT) program was initiated in a resident continuity clinic. Surveys of resident and staff knowledge and attitudes of OBOT were administered at baseline and 4 months. A retrospective chart review of the 15-month OBOT clinic obtained patient characteristics and outcomes.
RESULTS
Twelve patients with OUD were seen in the OBOT clinic. Seven patients (58%) were retained in care at the end of the study period for a range of 9-15 months. Eight patients demonstrated a good clinical response. Surveys of residents and staff at 4 months were unchanged from baseline showing persistent lack of comfort in caring for patients with OUD.
CONCLUSIONS
OBOT can be successfully integrated into resident continuity practices with positive patient outcomes. Improvement in resident and staff attitudes toward OBOT were not observed and likely require direct and frequent exposure to OUD care to increase acceptance.
Identifiants
pubmed: 31856915
doi: 10.1186/s13722-019-0175-z
pii: 10.1186/s13722-019-0175-z
pmc: PMC6921403
doi:
Substances chimiques
Narcotic Antagonists
0
Buprenorphine
40D3SCR4GZ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
46Subventions
Organisme : Research in Addiction Medicine Scholars (RAMS) Program
ID : R25DA033211
Pays : International
Références
Ann Intern Med. 2011 Jan 4;154(1):56-9
pubmed: 21200039
Subst Abus. 2013;34(3):242-7
pubmed: 23844954
J Gen Intern Med. 2005 Nov;20(11):1038-41
pubmed: 16307630
Am J Addict. 2001 Winter;10(1):40-7
pubmed: 11268827
Psychiatr Serv. 2018 Jul 1;69(7):768-776
pubmed: 29656707
Am J Addict. 2008 Mar-Apr;17(2):116-20
pubmed: 18393054
Subst Abus. 2006 Sep;27(3):39-45
pubmed: 17135179
J Addict Dis. 2005;24(2):25-32
pubmed: 15784521
JAMA. 2014 Aug 6;312(5):502-13
pubmed: 25096690
Psychol Addict Behav. 2011 Jun;25(2):215-24
pubmed: 21480679
Subst Abus. 2016 Oct-Dec;37(4):635-641
pubmed: 27164025
Drug Alcohol Depend. 2013 Jul 1;131(1-2):127-35
pubmed: 23332439
Subst Abus. 2012;33(2):103-13
pubmed: 22489582
J Opioid Manag. 2012 May-Jun;8(3):153-60
pubmed: 22798175
J Gen Intern Med. 2009 Jan;24(1):40-7
pubmed: 18937015
J Subst Abuse Treat. 2009 Dec;37(4):426-30
pubmed: 19553061
Subst Abus. 2015;36(4):427-33
pubmed: 25257796
N Engl J Med. 2014 May 29;370(22):2063-6
pubmed: 24758595
Subst Abus. 2018;39(4):434-440
pubmed: 29513136
Am J Public Health. 2015 Aug;105(8):e55-63
pubmed: 26066931
Subst Abus. 2004 Dec;25(4):11-5
pubmed: 16172088
Addiction. 2016 Apr;111(4):695-705
pubmed: 26599131
J Am Board Fam Med. 2011 Mar-Apr;24(2):194-201
pubmed: 21383220
Am J Addict. 2014 Nov-Dec;23(6):618-22
pubmed: 25065457
J Subst Abuse Treat. 2009 Apr;36(3):244-51
pubmed: 18715741
Rural Remote Health. 2015;15:3019
pubmed: 25651434
JAMA. 2016 Sep 20;316(11):1211-1212
pubmed: 27654608
Subst Abus. 2018;39(3):377-383
pubmed: 29452056
JAMA Psychiatry. 2015 Apr;72(4):395-6
pubmed: 25671806
Subst Abus. 2012;33(3):241-50
pubmed: 22738001
Cochrane Database Syst Rev. 2014 Feb 06;(2):CD002207
pubmed: 24500948
Acad Med. 2017 May;92(5):680-683
pubmed: 28441678
Fam Med. 2006 May;38(5):336-40
pubmed: 16673195
Subst Abus. 2007;28(4):79-92
pubmed: 18077305
Ann Fam Med. 2007 Mar-Apr;5(2):146-50
pubmed: 17389539
Arch Intern Med. 2011 Mar 14;171(5):425-31
pubmed: 21403039